Anesthesiology, Pain Medicine · Hainesport, NJ
NPI
1114089471
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
8
Medicare group memberships
Hospitals
1
Hospital affiliations
404 Creek Crossing Blvd
Hainesport, NJ, 08036
Phone (609) 845-3988
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
15,408 services
Medicare patients, 2024
1,387
Average age 66
Drug cost, 2024
$299K
1,062 prescriptions
Company payments, 2025
$4,644
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abhijeet Rastogi was code G0482 (drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms), 4,238 times for 1,120 patients. In total Abhijeet Rastogi billed 15,408 services in 56 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 4,238 | 1,120 | $194.77 | $825K |
| 80307 Drug Tests | Office | 4,226 | 952 | $60.76 | $257K |
| 99443 Telephone Services | Office | 1,977 | 667 | $106.24 | $210K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 1,074 | 273 | $50.65 | $54K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 788 | 335 | $153.18 | $121K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 765 | 333 | $13.37 | $10K |
| 99214 Office E&M - Established | Office | 740 | 394 | $93.81 | $69K |
| 99213 Office E&M - Established | Office | 438 | 232 | $63.75 | $28K |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 115 | 104 | $69.05 | $7,941 |
| 64493 Nerve Block Injection - Back | Office | 96 | 63 | $210.43 | $20K |
| 64494 Nerve Block Injection - Back | Office | 93 | 61 | $109.21 | $10K |
| 64483 Nerve Block Injection - Back | Office | 67 | 47 | $252.95 | $17K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 65 | 40 | $205.10 | $13K |
| 99204 Office E&M - New | Office | 64 | 63 | $127.28 | $8,146 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 58 | 40 | $376.75 | $22K |
By year: 2022 $1.2M for 13,605 services; 2023 $1.8M for 39,380 services; 2024 $1.8M for 15,408 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 4,238 | 1,120 | $194.77 | $825K |
| 80307 Drug Tests | 4,226 | 952 | $60.76 | $257K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 788 | 335 | $153.18 | $121K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 47 | 27 | $104.88 | $4,929 |
Medicare prescription drug claims, 2024
In 2024, the drug Abhijeet Rastogi prescribed most often to Medicare patients was Ztlido (Lidocaine), with 210 prescriptions and refills. In total Abhijeet Rastogi wrote 1,062 Medicare prescriptions that cost $299K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ztlido Lidocaine | 210 | 211 | 51 | $174K |
| Diclofenac Sodium Generic | 127 | 127 | 29 | $33K |
| Gabapentin Generic | 90 | 95 | 40 | $824 |
| Oxycodone Hcl Generic | 65 | 65 | 39 | $1,051 |
| Ibuprofen-Famotidine Ibuprofen/Famotidine | 54 | 54 | 12 | $12K |
| Lidocaine Generic | 53 | 58 | 14 | $8,412 |
| Diazepam Generic | 50 | 50 | 40 | $28.74 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 39 | 39 | 27 | $1,099 |
| Gralise Gabapentin | 38 | 38 | Under 11 | $14K |
| Pregabalin Generic | 26 | 33 | 18 | $578 |
| Celecoxib Generic | 25 | 25 | 17 | $573 |
| Tizanidine Hcl Generic | 23 | 25 | 12 | $181 |
| Methylprednisolone Generic | 20 | 20 | 18 | $99.85 |
| Buprenorphine Generic | 19 | 19 | 16 | $3,695 |
| Tramadol Hcl Generic | 17 | 17 | 12 | $55.92 |
Brand drugs: - claims; generic drugs: 687 claims; opioid claims: 202.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abhijeet Rastogi $4,644 ($4,644 in general payments such as food, travel and fees) from 13 companies. The largest payer was Spinal Simplicity, LLC with $2,454.
| Company | Payments | Amount |
|---|---|---|
| Spinal Simplicity, LLC | 9 | $2,454 |
| Foundation Fusion Solutions, LLC | 9 | $581 |
| Boston Scientific Corporation BSX | 16 | $551 |
| Abbott Laboratories ABT | 10 | $276 |
| Averitas Pharma Inc. | 4 | $244 |
| BIOTRONIK NRO, Inc. | 9 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $88.85 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $81.65 |
| Forte Bio-Pharma LLC | 4 | $74.51 |
| Saluda Medical Americas, Inc. | 2 | $58.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.